Drug Discovery Platform (Drug Discovery) Equipment
-
Manufactured by Verge Genomicsbased in USA
The breadth and depth of our pipeline demonstrates the power of the ConVERGEMplatform. All pipeline programs have been discovered and developed on our proprietary platform. ...
-
based in USA
ATX-Gx™, our first platform, is a royalty-free suite of immunocompetent transgenic mice enabling best-in-class in vivo human antibody discovery. There are three ways to access the ATX-Gx™ ...
-
based in SWITZERLAND
EraCal’s platform enables unbiased and large-scale in vivo drug discovery in zebrafish larvae. The journal Science Advances published part of EraCal’s translational proof of concept. Such phenotypic strategies are capable of identifying novel mechanisms of actions and, consequently, are a prime choice to discover first-in-class ...
-
Manufactured by Orbit Discoverybased in UNITED KINGDOM
Orbit presents DNA and peptide on the surface of a microbead. This allows for unbiased libraries and a tunable multivalent display that gives access to huge chemical diversity. Our display technology can deal with unnatural amino acids and complex peptide constraints. It can display a peptide via complex scaffolds and makes whole cell screening and functional hits possible. ...
-
based in USA
Opal is the first end-to-end integrated drug discovery & development platform. Traditional, linear approaches to target discovery and drug development have created sub-optimized systems that are intrinsically disintegrated and ...
-
Manufactured by Galapagos NVbased in BELGIUM
Filgotinib, a preferential JAK1 inhibitor, is marketed as Jyseleca in the European Union (incl. Norway), Great Britain, and Japan for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have responded inadequately or are intolerant to one or more disease modifying anti-rheumatic drugs ...
-
Manufactured by 3B Pharmaceuticals GmbHbased in GERMANY
3B Pharmaceuticals have built a drug discovery platform extending from hit identification to early clinical development. Several drug candidates developed through our platform already have been successfully administered to humans. ...
-
Manufactured by Benevolentbased in UNITED KINGDOM
The emerging global threat from COVID-19 demanded immediate action. With cases rising rapidly, we set up a specialist team to use our AI-drug discovery platform to search for existing drugs — already proven safe — that could be repurposed to treat the virus. We are the only AI company to successfully identify a ...
-
based in SWITZERLAND
G Protein-Coupled Receptors (GPCRs) are involved in a wide range of physiological and pathological processes and represent a large class of drug targets accounting for >30% of all drugs on the market. These drugs, however, only cover 15% of the entire GPCR family, and many valuable receptors remain undrugged. In particular, GPCRs whose ...
-
Manufactured by Juvena Therapeutics, inc.based in USA
Secreted proteins are a proven class of biologics with tremendous therapeutic potential, as they regulate tissue repair and regeneration, organ development, and immune response to disease. The characteristics of secreted proteins render them a rich pool of drug candidates for chronic and age-related diseases. Our therapeutic approach is to ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you